Moderna applies for Emergency approval from F.D.A for coronavirus vaccine

The world is eagerly waiting for the much awaited vaccine for coronavirus so that the pandemic can finally come to an end. Drug giant Moderna announced that it will be applying for an emergency use of for the coronavirus vaccine to the Food and Drug Administration on November 30, 2020. This would mean that if the road is smooth, then there are chances that the first injectables might come up as soon as December 21, 2020. Stephane Bancel, the chief executive of the company during an interview confirmed about the development.

The application by Moderna is expected to be based on the data that it has announced on November 30, 2020 and will be showing the it is 94.1 percent effective. The company has undertaken a study with 30,000 people who have met the criteria that is essential to determine that the vaccine is actually effective. The findings from the latest data are in line with the analysis of the earlier data that the company had released on November 16, 2020.

The latest data that has been released has claimed that the vaccine was 100 percent effective at preventing severe disease from coronavirus. The vaccine has been developed by the government researchers from the Vaccine Research Centre at the National Research of Allergy and Infectious Disease. Bancel while talking about the development has assured that it was preparing to produce 20 million vaccine doses by the end of December and about 500 million to a billion in 2021.

Every person will need to have two doses that will be administered a month apart which means that about 20 million doses would be enough for 10 million people. With the latest emergency application, Moderna has become the second company to apply for authorization. Earlier Pfizer has submitted its application on November 20, 2020 and has assured that it will be producing 50 million doses in 2020. The coronavirus pandemic started off in December 2019.

Photo Credits: Pixabay